BCBS and IOSCO Margin Guidance: Legacy Swaps Amended Solely for Benchmarks May Be Exempt from Margin Requirements | Practical Law

BCBS and IOSCO Margin Guidance: Legacy Swaps Amended Solely for Benchmarks May Be Exempt from Margin Requirements | Practical Law

BCBS and IOSCO jointly released guidance on the final implementation phases of margin requirements for non-centrally cleared derivatives, clarifying, among other things, that legacy derivatives contracts amended solely for benchmark reform purposes may remain exempt form new global margin requirements.

BCBS and IOSCO Margin Guidance: Legacy Swaps Amended Solely for Benchmarks May Be Exempt from Margin Requirements

by Practical Law Finance
Published on 06 Mar 2019USA (National/Federal)
BCBS and IOSCO jointly released guidance on the final implementation phases of margin requirements for non-centrally cleared derivatives, clarifying, among other things, that legacy derivatives contracts amended solely for benchmark reform purposes may remain exempt form new global margin requirements.
On March 5, 2019, the Basel Committee on Banking Supervision (BCBS) and the International Organization of Securities Commissions (IOSCO) jointly released guidance on the final implementation phases of margin requirements for non-centrally cleared derivatives.
The guidance clarifies that:
  • Market participants may need to amend derivatives contracts in response to interest rate benchmark reforms. If amendments to legacy derivatives contracts are made solely to address interest rate benchmark reforms, they do not require the application of the margin requirements for the purposes of the framework. (Amended swaps are often considered new swaps for purposes of application of new rules.) However, the guidance notes that this position may be different under relevant jurisdictional implementing laws.
  • In the remaining phases of the framework's implementation in 2019 and 2020, initial margin (IM) requirements will apply to a large number of entities for the first time and will potentially involve new documentation, custodial, and operational arrangements. BCBS and IOSCO note that the framework does not specify documentation, custodial, or operational requirements if the bilateral IM amount does not exceed the framework's €50 million IM threshold. However, covered entities are expected to act diligently when their exposures approach the threshold to ensure that the relevant arrangements needed are in place if the threshold is exceeded.
BCBS and IOSCO will continue to monitor the effect of meeting the final stage of phase-in that is scheduled for 2020.